Comparison of Outcome Between Low-Dose Rabbit Anti-Thymocyte Globulin and Basiliximab in Low-Risk Living Donor Kidney Transplantation

被引：0
|
作者：
Kim, S. [1 ]
Lim, M. [1 ]
Kwon, J. [1 ]
Jeong, E. [1 ]
Yang, J. [1 ]
Kim, K. [1 ]
Lee, K. [1 ]
Lee, O. [1 ]
Joh, J. [1 ]
机构：
[1] Samsung Med Ctr, Transplantat, Seoul, South Korea
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A-4
引用
下载
收藏
页码：904 / 904
页数：1
相关论文
共 50 条
  • [31] Efficacy of Early Steroid Withdrawal with Anti-Thymocyte Globulin Induction - Optimal Dose of Anti-Thymocyte Globulin in Korean Kidney Transplantation -
    Park, J. B.
    Chng, Y. S.
    Kim, Y. H.
    Song, K. B.
    Jung, J. H.
    Kim, S-C
    Han, D. J.
    TRANSPLANTATION, 2012, 94 (10) : 989 - 989
  • [32] Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources
    Shichijo, Takafumi
    Fuji, Shigeo
    Tajima, Kinuko
    Kubo, Hiroyuki
    Nozaki, Kenji
    Honda, Tadahiro
    Yamaguchi, Junko
    Kawashima, Ichiro
    Kawajiri, Akihisa
    Takemura, Tomonari
    Onishi, Akio
    Ito, Ayumu
    Tanaka, Takashi
    Inamoto, Yoshihiro
    Kurosawa, Saiko
    Kim, Sung-Won
    Fukuda, Takahiro
    BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 634 - 639
  • [33] Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources
    Takafumi Shichijo
    Shigeo Fuji
    Kinuko Tajima
    Hiroyuki Kubo
    Kenji Nozaki
    Tadahiro Honda
    Junko Yamaguchi
    Ichiro Kawashima
    Akihisa Kawajiri
    Tomonari Takemura
    Akio Onishi
    Ayumu Ito
    Takashi Tanaka
    Yoshihiro Inamoto
    Saiko Kurosawa
    Sung-Won Kim
    Takahiro Fukuda
    Bone Marrow Transplantation, 2018, 53 : 634 - 639
  • [34] Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy for Simultaneous Heart-Kidney Transplantation in the Contemporary Era
    Huang, X.
    Carver, B.
    Choe, J.
    Salerno, D.
    Shertel, T.
    Colombo, P. C.
    Yuzefpolskaya, M.
    Jennings, D. L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S638 - S638
  • [35] Rabbit Anti-Thymocyte Globulin: Evidence for Clinical Benefit in High Immunological Risk Kidney Transplantation
    Mai, Martin L.
    Wadei, Hani
    Gonwa, Thomas A.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 39 - 49
  • [36] Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients
    Abou-Jaoude, MM
    Ghantous, I
    Najm, R
    Afif, C
    Almawi, WY
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2731 - 2732
  • [37] RABBIT ANTI-THYMOCYTE GLOBULIN (rATG)-BASED IMMUNOSUPPRESSION INDUCTION IN KIDNEY TRANSPLANTATION
    Goggins, William C.
    Qualey, Angie
    Taber, Tim
    Powelson, John
    Chen, Jeanne
    Robertson, Chris
    Mangus, Richard S.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 180
  • [38] Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation
    Sageshima, Junichiro
    Ciancio, Gaetano
    Guerra, Giselle
    Gaynor, Jeffrey J.
    Cova, Deborah
    Zarak, Alberto
    Chen, Linda
    Mattiazzi, Adela
    Kupin, Warren
    Roth, David
    Hanson, Lois
    Livingstone, Alan S.
    Ruiz, Phillip
    Burke, George W.
    TRANSPLANT IMMUNOLOGY, 2011, 25 (2-3) : 104 - 111
  • [39] Outcomes after anti-thymocyte globulin vs Basiliximab induction before deceased donor kidney transplants
    Hafeez, Muhammad Saad
    Ul Haq, Muneeb
    Bakhthiyar, Syed Shahyan
    Azhar, Kumael
    Awan, Ahmed Arslan Yousuf
    Murthy, Bhamidipati V. Ramana
    Abbas, Rana
    TRANSPLANT IMMUNOLOGY, 2022, 75
  • [40] Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
    Ansari, David
    Hoglund, Peter
    Andersson, Bodil
    Nilsson, Johan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01):
12345